Iovance Biotherapeutics is a biotechnology company that develops cell therapies for cancer, based in California. Its work centres on tumor-infiltrating lymphocyte therapies, in which immune cells taken from a patient's own tumour are grown outside the body and returned to the patient. The company's main approved treatment is used for certain patients with advanced melanoma, and it also studies these therapies in other solid tumours. Its customers are cancer treatment centres and the clinicians who care for patients with advanced disease.
The shares are listed on the London Exchange in UK under the code 0JDK, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #681 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
92/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average162.8%
From 52-week high-6.1%
MomentumStrong
100/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return170.8%
6-month return309.9%
12-month, skipping last month345.0%
Stability (higher is calmer)Weak
19/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)95.0%
Worst drawdown, 1 year (smaller is calmer)-39.0%
LiquidityFair
56/100
Moderate trading activity.
See the numbers →
Avg daily value traded1.42M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 1.76 – 15.30Daily closes, split-adjusted
Signals
50-day average10.26
200-day average5.36
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.93
Technical summary
Daily
Strongly bullish
11 bullish · 4 neutral · 1 bearish
Weekly
Strongly bullish
11 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
14.02
Bullish
EMA 10
13.98
Bullish
SMA 20
13.30
Bullish
EMA 20
13.14
Bullish
SMA 50
10.26
Bullish
EMA 50
10.76
Bullish
SMA 100
7.33
Bullish
EMA 100
8.48
Bullish
SMA 200
5.36
Bullish
EMA 200
6.48
Bullish
Oscillators (daily)
RSI (14)
64.17
Neutral
MACD (12, 26)
1.25
Bullish
Momentum (12)
-1.61
Bearish
Stochastic %K (14)
62.72
Neutral
Williams %R (14)
-37.28
Neutral
CCI (20)
44.34
Neutral
Pivot points (classic, last session)
S3
12.27
S2
12.89
S1
13.49
Pivot
14.11
R1
14.71
R2
15.33
R3
15.93
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
